Halpod 200 DT Tablet contains Cefpodoxime Proxetil 200 mg, a third-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. It is indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, otitis media, and gonorrhea caused by susceptible strains of bacteria. Cefpodoxime Proxetil works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death, thereby exerting a bactericidal effect. The tablet is designed for oral administration and features a dispersible formulation that facilitates ease of use, particularly in pediatric and geriatric populations. Halpod 200 DT demonstrates good oral bioavailability and achieves effective tissue penetration, ensuring optimal therapeutic outcomes. It is generally well-tolerated; however, adverse reactions may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain, as well as hypersensitivity reactions in susceptible individuals. Caution is advised in patients with a history of penicillin or cephalosporin allergy. Dosage adjustments may be necessary in patients with renal impairment. As with all antibiotics, it is essential to complete the prescribed course to prevent the development of resistance. Halpod 200 DT should be used under medical supervision, with adherence to recommended dosing guidelines to ensure safety and efficacy.